Abstract
The approved maximal dose of sildenafil is only 50 mg in Japan, but the impact of dose regulation on treatment outcomes has not been established. Moreover, the contributors to the efficacy in patients having an intact peripheral nervous system have not been fully elucidated. We assessed in Japanese patients the treatment outcomes of sildenafil for erectile dysfunction (ED) under regulation of the approved dose and identified factors contributing to its efficacy among those with various etiologies other than pelvic surgery. We retrospectively reviewed 196 ED patients treated with sildenafil. The overall efficacy was 70.9% (139/196), and patients with psychological problems and concomitant cardiovascular disease showed high response rates (82.4 and 87.0%, respectively). Of the 139 responders, 89.9% achieved efficacy with a dose of 25 or 50 mg. Logistic regression analysis revealed concomitant cardiovascular disease and a favorable nocturnal penile tumescence result to be independent contributors to the efficacy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 8 print issues and online access
$259.00 per year
only $32.38 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA . Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N Engl J Med 1998; 338: 1397–1404.
Carson CC, Burnett AL, Levine LA, Nehra A . The efficacy of sildenafil citrate (Viagra) in clinical populations: an update. Urology 2002; 60: 12–27.
Carson III CC . Sildenafil: a 4-year update in the treatment of 20 million erectile dysfunction patients. Curr Urol Rep 2003; 4: 488–496.
Suzuki K, Sato Y, Horita H, Adachi H, Kato R, Hisasue S et al. The correlation between penile tumescence measured by the erectometer and penile rigidity by the RigiScan. Int J Urol 2001; 8: 594–598.
Martinez-Jabaloyas JM, Gil-Salom M, Villamon-Fort R, Pastor-Hernandez F, Martinez-Garcia R, Garcia-Sisamon F . Prognostic factors for response to sildenafil in patients with erectile dysfunction. Eur Urol 2001; 40: 641–646; discussion 647.
NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. JAMA 1993; 270: 83–90.
Morales A, Lunenfeld B . Investigation, treatment and monitoring of late-onset hypogonadism in males. Official recommendations of ISSAM. International Society for the Study of the Aging Male. Aging Male 2002; 5: 74–86.
Vermeulen A, Verdonck L, Kaufman JM . A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999; 84: 3666–3672.
Matsuda T, Tatsumi M . Diagnosis and treatment of partial androgen deficiency in aging male. Jpn J Urol Surg 2003; 16: 831–837.
Ochiai A, Naya Y, Soh J, Ishida Y, Mizutani Y, Kawauchi A et al. Efficacy of sildenafil as the first-step therapeutic tool for Japanese patients with erectile dysfunction. Int J Impot Res 2005; 17: 339–342.
Masumori N, Tsukamoto T, Kumamoto Y, Panser LA, Rhodes T, Girman CJ et al. Decline of sexual function with age in Japanese men compared with American men – results of two community-based studies. Urology 1999; 54: 335–344; discussion 344–335.
Zippe CD, Kedia AW, Kedia K, Nelson DR, Agarwal A . Treatment of erectile dysfunction after radical prostatectomy with sildenafil citrate (Viagra). Urology 1998; 52: 963–966.
Raina R, Lakin MM, Agarwal A, Sharma R, Goyal KK, Montague DK et al. Long-term effect of sildenafil citrate on erectile dysfunction after radical prostatectomy: 3-year follow-up. Urology 2003; 62: 110–115.
Burchardt M, Burchardt T, Baer L, Kiss AJ, Pawar RV, Shabsigh A et al. Hypertension is associated with severe erectile dysfunction. J Urol 2000; 164: 1188–1191.
Marumo K, Nakashima J, Murai M . Age-related prevalence of erectile dysfunction in Japan: assessment by the International Index of Erectile Function. Int J Urol 2001; 8: 53–59.
Naya Y, Mizutani Y, Ochiai A, Soh J, Kawauchi A, Fujito A et al. Preliminary report of association of chronic diseases and erectile dysfunction in middle-aged men in Japan. Urology 2003; 62: 532–536.
Jarow JP, Burnett AL, Geringer AM . Clinical efficacy of sildenafil citrate based on etiology and response to prior treatment. J Urol 1999; 162: 722–725.
Shirai M, Thukamoto T, Sato Y, Horita H, Kato S, Yachiku S et al. Randomized, placebo-controlled, double-blind study of oral sildenafil in Japanese men with erectile dysfunction. Nishinihon J Urol 2000; 62: 373–383.
Choi HK, Ahn TY, Kim JJ, Kim SC, Paick JS, Suh JK et al. A double-blind, randomised-placebo, controlled, parallel group, multicentre, flexible-dose escalation study to assess the efficacy and safety of sildenafil administered as required to male outpatients with erectile dysfunction in Korea. Int J Impot Res 2003; 15: 80–86.
Lim PH, Li MK, Ng FC, Chia SJ, Consigliere D, Gooren L et al. Clinical efficacy and safety of sildenafil citrate (Viagra) in a multi-racial population in Singapore: A retrospective study of 1520 patients. Int J Urol 2002; 9: 308–315.
Padma-nathan H, Eardley I, Kloner RA, Laties AM, Montorsi F . A 4-year update on the safety of sildenafil citrate (Viagra). Urology 2002; 60: 67–90.
Atiemo HO, Szostak MJ, Sklar GN . Salvage of sildenafil failures referred from primary care physicians. J Urol 2003; 170: 2356–2358.
El-Galley R, Rutland H, Talic R, Keane T, Clark H . Long-term efficacy of sildenafil and tachyphylaxis effect. J Urol 2001; 166: 927–931.
McCullough AR, Barada JH, Fawzy A, Guay AT, Hatzichristou D . Achieving treatment optimization with sildenafil citrate (Viagra) in patients with erectile dysfunction. Urology 2002; 60: 28–38.
Cayan S, Bozlu M, Canpolat B, Akbay E . The assessment of sexual functions in women with male partners complaining of erectile dysfunction: does treatment of male sexual dysfunction improve female partner's sexual functions? J Sex Marital Ther 2004; 30: 333–341.
Hisasue S, Kumamoto Y, Sato Y, Masumori N, Horita H, Kato R et al. Prevalence of female sexual dysfunction symptoms and its relationship to quality of life: a Japanese female cohort study. Urology 2005; 65: 143–148.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kobayashi, K., Hisasue, S., Kato, R. et al. Outcome analysis of sildenafil citrate for erectile dysfunction of Japanese patients. Int J Impot Res 18, 302–305 (2006). https://doi.org/10.1038/sj.ijir.3901400
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijir.3901400